"CoxHealth in Springfield, MO is the area leader in health care and community involvement, with six hospitals, more than 80 clinics, five ERs and nearly 12,000 employees throughout southwest Missouri. We offer a wide range of treatments and services to help with whatever health needs you might have. Whether you're about to become a parent, have an illness or need medical information, we're here for you. And if your goal is to live a healthy, balanced life with the best tools available, we can help with that, too."

During the past decade, Hulston Cancer Center at Cox Medical Center South conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 69 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 9 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hulston Cancer Center at Cox Medical Center South" #1 sponsor was "SWOG Cancer Research Network" with 42 trials, followed by "Alliance for Clinical Trials in Oncology" with 33 trials sponsored, "Radiation Therapy Oncology Group" with 18 trials sponsored, "Gynecologic Oncology Group" with 15 trials sponsored and "NSABP Foundation Inc" with 15 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hulston Cancer Center at Cox Medical Center South" #1 collaborator was "National Cancer Institute (NCI)" with 130 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator, "NCIC Clinical Trials Group" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator and "SWOG Cancer Research Network" with 5 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Hulston Cancer Center at Cox Medical Center South" are "Breast Cancer" (31 trials), "Lung Cancer" (16 trials), "Ovarian Cancer" (10 trials), "Lymphoma" (8 trials) and "Primary Peritoneal Cavity Cancer" (8 trials). Many other conditions were trialed in "Hulston Cancer Center at Cox Medical Center South" in a lesser frequency.

Most popular intervention types in "Hulston Cancer Center at Cox Medical Center South" are "Drug" (103 trials), "Biological" (34 trials), "Radiation" (34 trials), "Other" (28 trials) and "Procedure" (21 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (18 trials), "cisplatin" (14 trials), "paclitaxel" (13 trials), "carboplatin" (11 trials) and "docetaxel" (11 trials). Other intervention names were less common.

The vast majority of trials in "Hulston Cancer Center at Cox Medical Center South" are 87 trials for "All" genders, 41 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Hulston Cancer Center at Cox Medical Center South". undefined are not yet recruiting, undefined are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 102 completed trials in Hulston Cancer Center at Cox Medical Center South, undefined suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in Hulston Cancer Center at Cox Medical Center South, 2 "Phase 1" clinical trials were conducted, 64 "Phase 2" clinical trials and 51 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".